BRCA1 and cancer: The high penetrance of the BRCA1 gene was recognized early on in the course of BRCA1 characterization by analyses showing that mutation carriers have an increased lifetime risk of developing breast (40–85%) and/or ovarian (16–64%) cancers (3–8).